© Copyright RiverVest® All Rights Reserved.
Pascal Krotee, Ph.D. is a principal at RiverVest Venture Partners, where she focuses on sourcing and completing due diligence on prospective portfolio companies in both the biopharmaceutical and medical device sectors.
RiverVest has an extraordinary track record of creating and investing in groundbreaking and successful technologies that change patients' lives for the better. They have achieved these results by putting collaboration, innovation, and transparency above all else. I am thrilled to be part of the team."
Pascal Krotee,
Ph.D.
PRINCIPAL
SAN DIEGO, CALIFORNIA
JOINED IN 2021
Pascal Krotee, Ph.D., joined RiverVest in 2021 as a senior associate and was promoted to principal in 2023. With her versatile background, Pascal focuses on sourcing and completing due diligence on prospective portfolio companies in both the biopharmaceutical and medical device sectors. Based in San Diego, Pascal provides key operational support for RiverVest’s portfolio companies. She is a board member at Bluejay Therapeutics and at a stealth RiverVest portfolio company, and she acts as a board observer at Avalyn Pharma and Biolinq.
Prior to joining the RiverVest team, Pascal spent nearly four years as an investment associate at Kairos Ventures, where she focused on investments in the life sciences. While at Kairos, she sourced new opportunities for investment, led due diligence, and served on the Board of Directors of several portfolio companies.
Pascal earned a Ph.D. in Molecular Biology at UCLA, where she studied the atomic structures of proteins associated with Alzheimer’s disease and type-II diabetes and worked to create compounds that inhibited these structures. Prior to graduate school, Pascal worked as junior specialist at the Development Biology Center at the University of California, Irvine, where she had earned a B.S. in Developmental and Cell Biology with a Minor in Business Management.
Pascal is a 2023 winner of Biocom California’s Life Science Catalyst Award, recognizing her as a top-ten life science trailblazer under the age of forty across California.